adenocarcinoma in situ
Showing 1 - 25 of 2,909
Lung Adenocarcinoma, Frozen Section, Sublobar Resection Trial in Shanghai (Sublobar Resection)
Recruiting
- Lung Adenocarcinoma
- +2 more
- Sublobar Resection
-
Shanghai, Shanghai, ChinaFudan University Cancer Center
Sep 4, 2023
Adenocarcinoma of the Uterine Cervix and HPV
Not yet recruiting
- Adenocarcinoma of the Uterine Cervix
- Conization and/or Hysterectomy
- (no location specified)
May 23, 2022
Adenocarcinoma of the Pancreas Trial in Miami (Durvalumab, Radiation Therapy)
Active, not recruiting
- Adenocarcinoma of the Pancreas
- Durvalumab
- Radiation Therapy
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Jul 7, 2022
Primary Cervical Cancer Screening by Self-sampling HPV Test
Recruiting
- Human Papillomavirus Infection
- +16 more
-
Beijing, Beijing, China
- +5 more
Jan 12, 2023
Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma Trial in Richmond, South Hill (External Beam Radiation
Active, not recruiting
- Breast Cancer
- +4 more
- External Beam Radiation Therapy
- +2 more
-
Richmond, Virginia
- +1 more
Dec 16, 2022
In Era of HPV Vaccine, What Are The Current HPV Subtypes
Recruiting
- HSIL, High-Grade Squamous Intraepithelial Lesions
- +2 more
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Sep 21, 2021
Clinical Evaluation of Detection of High Risk HPV in Urine
Recruiting
- Human Papillomavirus Infection
- +17 more
-
Beijing, Beijing, China
- +2 more
Jan 21, 2022
Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage I
Recruiting
- Clinical Stage 0 Gastric Cancer AJCC v8
- +27 more
- Fluorouracil
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jul 5, 2022
Breast Adenocarcinoma, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Houston (Accelerated Partial Breast
Recruiting
- Breast Adenocarcinoma
- +9 more
- Accelerated Partial Breast Irradiation
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 21, 2021
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +85 more
- Patient Monitoring System
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Sep 7, 2022
Cervical Intraepithelial Neoplasia Grade 2/3, Adenocarcinoma in Situ Trial in Finland (Frequent information of cytological/ HPV
Enrolling by invitation
- Cervical Intraepithelial Neoplasia Grade 2/3
- Adenocarcinoma in Situ
- Frequent information of cytological/ HPV DNA screening results
-
Helsinki, Finland
- +17 more
Apr 22, 2021
Ocular Tumors Based on New Artificial Intelligence Algorithm
Not yet recruiting
- Melanoma (Skin)
- +6 more
- (no location specified)
Jan 4, 2021
Remote Telemonitoring of Patient-Generated Physiologic Health
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +171 more
- Patient Monitoring
- Questionnaire Administration
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Locally Advanced Malignant Solid Tumor, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United
Recruiting
- Locally Advanced Malignant Solid Neoplasm
- +3 more
- Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949
- VLP-encapsulated TLR9 Agonist CMP-001
-
Scottsdale, Arizona
- +3 more
Jun 1, 2022
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial
Withdrawn
- Anatomic Stage 0 Breast Cancer AJCC v8
- +28 more
- Carbon Dioxide Fractional Laser
- Questionnaire Administration
- (no location specified)
Jan 5, 2023
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in
Recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +23 more
- Quality-of-Life Assessment
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Nov 9, 2022
Improving Quality of Life in Stage 0-IIIC Gastric Cancer
Recruiting
- Clinical Stage 0 Gastric Cancer AJCC v8
- +17 more
- Best Practice
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Cervical Adenocarcinoma, Cervical Adenocarcinoma In Situ, Cervical Intraepithelial Neoplasia Trial in Houston (Biospecimen
Recruiting
- Cervical Adenocarcinoma
- +54 more
- Biospecimen Collection
- Laboratory Biomarker Analysis
-
Houston, Texas
- +1 more
Nov 30, 2020
CT-based Radiomic Algorithm for Assisting Surgery Decision and
Recruiting
- Predictive Cancer Model
- +2 more
- Radiomic Algorithm
-
Guangzhou, Guangdong, China
- +2 more
Jun 29, 2020
Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical
Active, not recruiting
- Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ
- V501
-
Yangchun, Guangdong, ChinaYangchun Center For Disease Prevention And Control ( Site 0003)
Aug 14, 2020
Invasiveness for Small-sized Lung Adenocarcinoma
Recruiting
- Lung Adenocarcinoma, Stage I
- Invasiveness diagnosis
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Apr 13, 2023
Lung Cancer Stage I, Quality of Life Trial in Fuzhou
Recruiting
- Lung Cancer Stage I
- Quality of Life
-
Fuzhou, Fujian, ChinaMaohui Chen
Aug 28, 2023
Human Papillomavirus Infection Trial in Guangzhou, Nanjing, Taiyuan (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58)
Active, not recruiting
- Human Papillomavirus Infection
- Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
- Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)(GARDASIL®)
-
Guangzhou, Guangdong, China
- +2 more
Dec 30, 2022
Papillomavirus Infections, Uterine Cervical Tumors, Vulvar Tumors Trial in Hanoi (9vHPV vaccine)
Completed
- Papillomavirus Infections
- +5 more
- 9vHPV vaccine
-
Hanoi, VietnamNational Institute of Hygiene and Epidemiology ( Site 0001)
Feb 14, 2020
Borderline Resectable Pancreatic Cancer Trial in Verona (Intraoperative radiotherapy)
Suspended
- Borderline Resectable Pancreatic Cancer
- Intraoperative radiotherapy
-
Verona, ItalyGeneral and Pancreatic Surgery Unit, Pancreas Institute, Univers
Nov 1, 2022